Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.

Our findings suggest a key role for DDR1 signaling in mediating the aggressive phenotype of gastric carcinoma. Importantly, inhibition of DDR1 is an attractive strategy for gastric carcinoma therapy.